Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 73.94
+2.33 (3.25%)
At close: Sep 17, 2026
Citi Pharma Balance Sheet
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 321.07 | 603.55 | 87.9 | 54.61 | 27.48 | 3,074 |
Short-Term Investments | 3.12 | 919.59 | 1,222 | 1,393 | 1,660 | - |
Trading Asset Securities | - | 66.5 | 108.81 | 132.36 | 312.12 | - |
Cash & Short-Term Investments | 324.19 | 1,590 | 1,418 | 1,580 | 2,000 | 3,074 |
Cash Growth | -75.43% | 12.08% | -10.26% | -20.97% | -34.96% | 3337.25% |
Accounts Receivable | 4,217 | 3,078 | 2,197 | 1,882 | 1,402 | 444.55 |
Other Receivables | - | 150.02 | 203.26 | 96.29 | 45.77 | - |
Receivables | 4,217 | 3,228 | 2,400 | 1,978 | 1,447 | 444.55 |
Inventory | 4,407 | 3,930 | 3,203 | 2,609 | 1,692 | 778.19 |
Other Current Assets | 1,023 | 723.98 | 613.03 | 415.98 | 458.15 | 204.08 |
Total Current Assets | 9,971 | 9,472 | 7,635 | 6,584 | 5,597 | 4,501 |
Property, Plant & Equipment | 8,624 | 8,688 | 3,530 | 3,122 | 2,258 | 1,735 |
Long-Term Accounts Receivable | - | - | - | 23.65 | - | 8.61 |
Other Long-Term Assets | 282.33 | 279.98 | 274.76 | 254.54 | 272.06 | 254.54 |
Total Assets | 18,878 | 18,439 | 11,439 | 9,984 | 8,127 | 6,499 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 3,599 | 3,479 | 3,374 | 1,938 | 1,618 | 993.58 |
Accrued Expenses | 86.08 | 236.33 | 216.54 | 206.62 | 149.67 | 58.54 |
Short-Term Debt | 3,420 | 2,869 | 1,437 | 1,768 | 521.57 | 12.2 |
Current Portion of Long-Term Debt | - | - | 12.86 | 55.88 | 160.69 | 108.71 |
Current Portion of Leases | 62.19 | 15.8 | 5.42 | 5.67 | 4.77 | 2.99 |
Current Income Taxes Payable | 464.13 | 519.68 | 470.83 | 393.19 | 404.18 | 126.87 |
Current Unearned Revenue | - | - | 0.58 | 3.04 | 14.51 | 5.86 |
Other Current Liabilities | 2.5 | 185.89 | 83.03 | 82.1 | 137.28 | 526.77 |
Total Current Liabilities | 7,633 | 7,305 | 5,599 | 4,453 | 3,010 | 1,836 |
Long-Term Debt | 30.71 | - | - | 8.54 | 250.17 | 189.16 |
Long-Term Leases | 53.21 | 64.86 | - | 4.37 | 6.27 | 7.76 |
Long-Term Unearned Revenue | - | - | - | 0.58 | 32.17 | 9.27 |
Pension & Post-Retirement Benefits | - | 99.7 | 82.62 | 50.34 | 31.94 | 14.25 |
Long-Term Deferred Tax Liabilities | - | 102.07 | 124.09 | 94.24 | 82.3 | 77.17 |
Other Long-Term Liabilities | 208.73 | 0 | - | - | - | -0 |
Total Liabilities | 7,926 | 7,572 | 5,806 | 4,611 | 3,413 | 2,133 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 2,285 | 2,285 | 2,285 | 2,285 | 2,285 | 1,350 |
Additional Paid-In Capital | 1,392 | 1,392 | 1,392 | 1,392 | 1,392 | - |
Retained Earnings | 1,891 | 1,807 | 1,648 | 1,388 | 728.54 | 380.61 |
Comprehensive Income & Other | 5,385 | 5,385 | 309.29 | 309.29 | 309.29 | 2,635 |
Shareholders' Equity | 10,951 | 10,868 | 5,633 | 5,373 | 4,714 | 4,366 |
Total Liabilities & Equity | 18,878 | 18,439 | 11,439 | 9,984 | 8,127 | 6,499 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 3,566 | 2,950 | 1,455 | 1,843 | 943.48 | 320.81 |
Net Cash (Debt) | -3,242 | -1,360 | -36.55 | -262.2 | 1,056 | 2,754 |
Net Cash Growth | - | - | - | - | -61.65% | - |
Net Cash Per Share | -14.20 | -5.95 | -0.16 | -1.15 | 4.66 | 14.77 |
Filing Date Shares Outstanding | 228.46 | 228.46 | 228.46 | 228.46 | 228.46 | 148.5 |
Total Common Shares Outstanding | 228.46 | 228.46 | 228.46 | 228.46 | 228.46 | 148.5 |
Working Capital | 2,338 | 2,166 | 2,035 | 2,131 | 2,586 | 2,666 |
Book Value Per Share | 47.94 | 47.57 | 24.66 | 23.52 | 20.63 | 29.40 |
Tangible Book Value | 10,951 | 10,868 | 5,633 | 5,373 | 4,714 | 4,366 |
Tangible Book Value Per Share | 47.94 | 47.57 | 24.66 | 23.52 | 20.63 | 29.40 |
Land | - | 6,940 | 1,865 | 1,865 | 1,421 | 1,049 |
Buildings | - | 673.95 | 661.56 | 485.03 | 309.33 | 214.96 |
Machinery | - | 1,758 | 1,525 | 1,194 | 915.01 | 795.57 |
Construction In Progress | - | 49.11 | 130.04 | 70.39 | 14.33 | - |